To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

Quarterly results

rupeeShow figures in :
rupeeShow figures in :

Quarterly results

Quarter ended on March 31, 2025Data in Crores of INR
Revenue
502.45+10.86% from last year
Operating profits
193.80+19.25% from last year
Net income
145.20+19.83% from last year

Financial reports

Data is unavailable

INCOME STATEMENTinfo2
Data in Crores of INR

Data is unavailable

BALANCE SHEETinfo2
Data in Crores of INR
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Net worth2315.711880.481483.931185.83947.91632.91363.83224.76128.1493.1961.7443.14
Fixed assets452.66279.81286.57305.34272.50226.84169.48151.83144.23113.13102.2432.71
Debt0.283.410.5017.0736.480.540.540.722.002.093.334.70
docView detailed balance sheet
arrow
CASH FLOWinfo2
Data in Crores of INR
FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014FY2013
Operating318.39271.37336.73268.6144.6883.4266.4967.6142.4049.8859.8331.95
Investing -320.04-217.58-376.77-29.44-54.50-100.46-69.02-36.11-5.72-22.66-43.89-45.44
Financing -38.07-28.17-40.68-23.9879.7789.79-11.60-6.74-13.95-8.67-5.96-1.48

Financial ratios

Profitability ratiosinfo2
ROA18.98%
ROE22.97%
ROCE26.92%
EPS60.18%
Net profit margin27.24%
Operating profit margin36.5%
Dividend per share5%
Operational ratiosinfo2
Quick ratio4.62%
Current ratio5.71%
Interest coverage724.63%
Assets turnover0.7%
Debt to equity
Valuation ratiosinfo2
P/E ratio29.07%
P/B ratio5.47%
Dividend yield0.15%
EV/EBITDA
Caplin Point Laboratories was established in 1990 to manufacture a range of ointments, creams and other external applications. It is the mid-sized company in India’s pharmaceutical sector to be engaged in the manufacture of APIs, finished formulations, research & development, clinical research, frontend generic presence in Latin America, brand marketing in Francophone Africa and an USFDA approved injectable facility.
personal

Grow your wealth with more research recommendations

+91